| Identification | Back Directory | [Name]
2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine | [CAS]
1052686-60-8 | [Synonyms]
2-Methoxypyrimidine-5-boronic acid pinacol ester
2-Methoxypyrimidin-5-ylboronic acid pinacol ester
2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
Pyrimidine, 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine ISO 9001：2015 REACH | [Molecular Formula]
C11H17BN2O3 | [MDL Number]
MFCD13182190 | [MOL File]
1052686-60-8.mol | [Molecular Weight]
236.08 |
| Chemical Properties | Back Directory | [Boiling point ]
354.3±34.0 °C(Predicted) | [density ]
1.10±0.1 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [pka]
0.94±0.22(Predicted) | [Appearance]
White to off-white Solid |
| Hazard Information | Back Directory | [Synthesis]
A solvent mixture (DME/H2O/Toluene/EtOH = 10:1:6:7, 7 mL) of 5-bromo-2-methoxypyrimidine (800 mg, 4.26 mmol) and potassium acetate (1.25 g, 12.77 mmol) was added to the reaction vial. Pd(dppf)Cl2-DCM (700 mg, 0.85 mmol) and bis(pinacolato)diboron (2.44 g, 9.6 mmol) were subsequently added. The reaction mixture was degassed and replaced three times with nitrogen before the reaction was stirred at 85 °C overnight. The reaction progress was monitored by TLC and after confirming the completion of the reaction, the reaction mixture was cooled to room temperature. The mixture was diluted with water (10 mL) and extracted with ethyl acetate (30 mL × 3). The organic phases were combined, dried with anhydrous Na2SO4, filtered and concentrated. Purification by silica gel column chromatography (eluent ratio PE:EA = 5:1) afforded the target product 2-methoxypyrimidine-5-boronic acid pinacol ester (24-4) as a yellow solid (1.0 g, 98% yield). | [References]
[1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 19, p. 5849 - 5853
[2] Patent: US9138427, 2015, B2. Location in patent: Page/Page column 290
[3] Patent: WO2017/197151, 2017, A1. Location in patent: Page/Page column 40 |
|
|